SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-181900
Filing Date
2015-05-11
Accepted
2015-05-11 16:06:53
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d913430d10q.htm 10-Q 519454
2 EX-31.1 d913430dex311.htm EX-31.1 6131
3 EX-31.2 d913430dex312.htm EX-31.2 5862
4 EX-32.1 d913430dex321.htm EX-32.1 4140
  Complete submission text file 0001193125-15-181900.txt   3184222

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT drna-20150331.xml EX-101.INS 334759
6 XBRL TAXONOMY EXTENSION SCHEMA drna-20150331.xsd EX-101.SCH 34199
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drna-20150331_cal.xml EX-101.CAL 45475
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drna-20150331_def.xml EX-101.DEF 102538
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE drna-20150331_lab.xml EX-101.LAB 252848
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drna-20150331_pre.xml EX-101.PRE 184342
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36281 | Film No.: 15850714
SIC: 2834 Pharmaceutical Preparations